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Aortic and large artery compliance in end-stage renal failure. Pulse
wave velocity (PWV) was measured in the aorta, right leg and arm of 90
control subjects (CS) and 92 hemodialysis patients (HD) of the same age
and mean arterial pressure (MAP). Blood chemistry, including blood
lipids, and echographic dimensions of the aorta, were measured in all
subjects. Presence of aortic calcification was evaluated by abdominal
X-ray and echography. Whereas femoral and brachial PWV were only
slightly increased in HD (P < 0.05), the aortic PWV was significantly
elevated (1113 319 cm/sec) in comparison with CS (965 216 cmlsec;
P = 0.0016). Aortic diameters were larger in HD, both at the root of
aorta (32.7 4 vs. 28.2 2.8 mm; P < 0.0001) and aortic bifurcation
(16.9 3.1 vs. 14.6 2.2 mm; P < 0.0001). Although the MAP was
similar in HD(109.9 19.3 mm Hg) and CS (110.2 17.2mmHg), the
pulse pressure was significantly increased in HD patients (76.6 23.7
vs. 63.9 22 mm Hg; P = 0.007). In the two populations, aortic PWV
was found to increase with age (P < 0.0001) and MAP (P < 0.0001). The
presence of aortic calcification showed only a borderline relationship
with the increase in aortic PWV (P = 0.050 in CS and P = 0.069 in HD).
As change in PWV is directly related to change in distensibility, and the
aortic diameters were increased in HD, these results indicate that aortic
wall compliance is decreased in HD, resulting in an increase in the
pulsatile component of arterial pressure. Alteration of pulsatile arterial
dynamics contributes to an increase in left ventricular load and is
significantly related to the left ventricular hypertrophy which is fre-
quently observed in these patients (P < 0.001).
The arterial system has two distinct and interrelated func-
tions: 1) to deliver an adequate supply of blood to body tissues
(the conduit function), and 2) to smooth out the pulsations
occurring with intermittent ventricular ejection (the cushioning
function) [1, 2].
The efficiency of the conduit function depends on the wide
arterial caliber and the constancy of a steady component of the
pressure wave [21. Abnormal conduit function results from the
narrowing of arterial (or artenolar) lumen, and has deleterious
effects on the organ and tissues downstream. The efficiency of
the cushioning function is altered principally by stiffening of the
vessel walls and alterations of the elastic properties of arteries,
and has deleterious effects on the heart upstream [21.
Abnormalities of the conduit function of arteries, especially
those affecting the coronary vessels, have been well docu-
mented in uremic patients on chronic hemodialysis. In these
patients ischemic heart disease due to coronary atherosclerosis
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is an important cause of mortality and morbidity [3]. However,
it has not been yet established whether the cushioning function
of the large arteries is altered in dialysis patients. The purpose
of this study was to investigate arterial distensibility in these
subjects.
Methods
Subjects
Ninety-two patients (48 men/44 women) on maintenance
dialysis were studied. The mean age of the hemodialysis pa-
tients (HD) was 49.9 15.9 years (13 to 83 years), and the
duration of dialysis was 3 to 205 months (78.6 63) (±sD). No
patient had a past history of ischemic heart disease, cerebrovas-
cular disease or peripheral artery disease, or diabetes or treated
hyperlipidemia. Thirty-two patients had a predialysis arterial
pressure higher than 160 and/or 90 mm Hg. In 17 HD, the body
fluid control by dialysis did not normalize the blood pressure
and they were referred to our department for detailed investi-
gation. They were not treated or had stopped all antihyperten-
sive therapy at least six weeks prior to the study. Eight patients
were smokers. In all patients, the peripheral pulses were
normal. The ankle/arm systolic pressure ratio was >1 in all
subjects.
The patients were dialyzed three times per week and the
duration of dialysis was individually adjusted (3 to 5 h) to
control body fluids and to maintain the predialysis serum urea at
less than 30 mmol/liter, serum creatinine at less than 1.1
mmollliter and serum electrolytes within the normal range.
Dialysis therapy was performed using dialyzers whose surface
area (1.2 to 2.1 m2) were matched to patient's body surface
area. Dialysate water was treated with reverse osmosis. The
dialysate was delivered by a system which included bicarbonate
delivery and ultrafiltration devices. An internal arteriovenous
fistula was used in all patients. Iron supplements were pre-
scribed routinely.
Ninety outpatients (49 menI4l women) with normal renal
function (serum creatinine < 0.12 mmollliter) were studied as
controls.
Arterial stiffness is largely influenced by age and arterial
pressure [2], and it was necessary to include in the control
population not only subjects of the same age and age range, but
also with the same arterial pressure and pressure range. There-
fore, the control group had to have the same proportion of
normotensive and hypertensive subjects as HD patients. For
this reason, thirty-two subjects with arterial pressure> 160/90
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mm Hg were included in the Control Group (CG). After
extensive investigation, they were all classified as essential
hypertensives. They were not treated or had stopped all anti-
hypertensive therapy at least six weeks prior to the study. No
subject had a past history of ischemic heart disease, cere-
brovascular disease, or peripheral artery disease or diabetes or
treated hyperlipidemia. Twenty-eight were smokers. In all
control subjects, the peripheral pulses were normal and the
ankle/arm systolic pressure ratio was >1. All gave informed
consent and the protocol was approved by the Institut National
de la Sante at de la recherche Médicale (INSERM).
Procedure
After initial screening, all the subjects were seen three times
at weekly intervals to determine reproducibility of the methods
and variability of the studied parameters. Dialysis patients were
examined before their midweek dialysis. All measurements
were taken during calm conditions at 21°C.
Arterial pressure was measured with a standard mercury
sphygmomanometer and cuffs adapted to arm circumference.
Systolic arterial pressure (SAP) was taken as the point of
appearance of Korotkov sounds, and diastolic arterial pressure
(DAP) as the point of disappearance of sounds (phase 5). Mean
arterial pressure (MAP) was calculated as MAP = DAP + (SAP
— DAP/3). Arterial pressure was recorded after the subject had
been recumbent for at least 10 minutes, before Doppler flow
recordings. A second measure was taken after the flow mea-
surement. On each occasion the pressure was measured three
times and averaged. As mentioned above, pressure and flow
measurements were repeated one and two weeks later in a
similar fashion. The values in the results are the averaged
values of all the measurements. In all subjects, the blood
pressure was measured by the same observer. Ankle systolic
arterial pressure (a.tibialis posterior) was measured using a 10
MHz ultrasonic flow detector and 18 cm wide standard cuff.
When the ankle/brachial artery pressure ratio exceeded 1.3, the
ankle systolic pressure was verified by mercury strain-gauge
plethysmography.
Arterial pulse wave velocity
The pressure or flow wave generated by ventricular ejection
is propagated throughout the arterial tree. Since the blood is
contained in a system of elastic conduits, energy propagation
occurs along the distensible artery wall and not through the
incompressible blood. The elastic properties of the arterial wall,
its thickness and the diameter are the major determinants of the
speed of propagation of the pulse wave, which determines
vascular impedance and total opposition to pulsatile flow [2].
These concepts have been formalized in mathematical models.
For large arteries, the most widely accepted relationship of
pulse wave velocity (PWV) and elastic modulus (E) is given by
the Moens Korteweg equation [2, 4]:
PWV = (EhI2rp)b'2
or by the Bramwell-Hill equation [2, 4]:
PWV =
where E = Young's modulus of the wall; h = wall thickness;
r = vessel radius; p = blood density; V, P changes in
volume and pressure; PV/V = relative volume distensibility.
Furthermore, the characteristic impedance of an arterial seg-
ment (Z0) is directly related to regional PWV as Z0 = PWVplin
[5]. Hence, valuable information on regional arterial distensi-
bility and impedance can be determined noninvasively as
regional PWV [2, 4, 5].
Transcutaneous Doppler flow recording. Three different
Doppler flow recordings were taken simultaneously at two
sites: (i) at the base of the neck over the common carotid artery
and the right femoral artery in the groin; (ii) over the right
femoral artery in the groin and the right posterior tibial artery;
(iii) over the right brachial artery in the axilla and right radial
artery at the wrist. In dialysis patients, the brachial and radial
artery flow recordings were done on the arm without arteriove-
nous fistula. Flow was measured with a nondirectional Doppler
unit (SEGA M842 10 MHz) with hand held probes. Transcuta-
neous Doppler flow waves were recorded on a Gould tape
recorder (M 8188) at high speed (100 or 200 mmlsec). Measure-
ments of flow were taken first from the common carotid and
femoral arteries, then from the femoral and posterior tibial
arteries, and finally from the brachial and radial arteries.
Determination of PWV. PWV was determined as foot-to-foot
wave velocity [2, 6]. The foot of the flow wave was identified as
the point of the commencement of the sharp systolic upstroke.
When this point could not be defined precisely, a tangent was
drawn to the last part of the preceding flow wave and to the
upstroke of the next wave, and the foot wave was taken as the
point of intersection of these two lines [6]. The time delay was
measured between the feet of the flow waves recorded at these
different points, averaged over at least ten beats and designated
as pulse transit time (t). The distance travelled by the pulse was
measured over the surface of the body with a tape measure as
the distance between the different recording sites (D). Arterial
PWV was calculated over the three arterial segments as PWV =
D/t [6]. For the measurements of PWV between the base of the
neck and the femoral artery, the distance from the suprasternal
notch to the carotid location was subtracted from the total
distance to take into account the pulse travelling in the opposite
direction, the PWV being designated as aortic PWV. The
femoral PWV was designated as that between femoral artery
and tibia! artery, and the brachial PWV as that between brachial
and radial arteries [6]. The values shown and analyzed are the
average values of the three measurements made at one week
intervals. The individual week to week variability was ex-
pressed as the standard deviation divided by the mean value.
For the aortic PWV the mean variability was 5.3 3.6%, for the
femoral PWV 5.5 4%, and for the radial PWV 7.2 4%. All
determinations of the PWV were made by the same observer.
Aortic diameters determination. The diameter of the root of
the aorta was measured just above the semilunar valves with a
two-dimensional echocardiograph (Kontron RC 400) and M-
mode echocardiograph (Irrex) using a 2.25 MHz transducer.
The diameter of the abdominal aorta was measured just above
the aortic bifurcation. The aortic internal dimension was mea-
sured with a CGR Sonel 300 echocardiograph with a 3 to 7.5
MHz transducer. Both longitudinal and transverse scans were
made and the internal diameter of the abdominal aorta was
expressed as the average value. The reproducibility of the
measure was 5.2 2% for the diameter at the root of the aorta,
and 5.9 1.7% for that above the aortic bifurcation. Lateral
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abdominal X-rays were done to assess the presence of aortic
and arterial calcifications. Frontal pelvic X-rays were per-
formed to assess the presence of calcifications in the iliofemoral
arteries.
Echocardiographic measurements
Echocardiographic records were obtained in 62 control sub-
jects and in 89 HD patients. Two-dimensional echocardiog-
raphy was performed using a Roche Kontron R.T.400 apparatus
(Roche Lab, Nutley, New Jersey, USA). M-mode echocardiog-
raphy was performed with an IRREX ultrasonograph using a
2.25 MHz transducer and a Cardio 80 Hewlett Packard com-
puter (Elkhart, Indiana, USA). Echocardiograms were obtained
with the patients in the semi-recumbent, and left lateral position
from an echocardiographic window located in the third or
fourth intercostal space at the left sternal border. Echocardio-
graphic data were calculated on at least 10 high-quality cycles.
Left ventricular measurements were made according to the
recommendations of the American Society of Echocardiog-
raphy [7] and Penn conventions [8]. Left ventricular end-
diastolic dimension (LVEDiD), interventricular septal thick-
ness (IVST), and posterior wall thickness (PWT) made
according to the Penn convention were used to calculate the left
ventricular mass (LVM) [81:
LVM (g) — 1.04 ((LVEDiD + IVST + PWT)3X —
(LVEDiD)3')
The records were read by the same two observers.
Biochemical measurements. Blood samples were drawn after
an overnight fast of at least 12 hours. Routine biochemical
parameters were determined by standard methods using a
Technicon RA 1000 autoanalyzer. Serum cholesterol and tri-
glycerides were determined using standard methods on an
autoanalyzer. HDL cholesterol was determined in the superna-
tant after precipitation with heparin-MnC12 [9]. Apolipoproteins
Al and B were determined by the turbidimetric method [10].
Statistical analysis
Group data were expressed as the mean standard deviation
(SD). Comparison of the values of parameters between the
groups was made using Student's t-test. To assess the combined
influence of variables on arterial PWV, we used stepwise linear
regression analysis with forward and backward elimination
procedures. The model used the following variables: age, mean
blood pressure, duration of dialysis, blood lipids, the calcium-
phosphorus product, and the presence or absence of arterial
calcifications. Age, arterial pressure and biochemical variables
were continuous. Aortic and iliofemoral calcifications were
represented by a dummy variable (1:absent, 2:present). A value
of P < 0.05 was considered as significant. The statistical
analysis was performed on an IBM AT computer using the
Number Cruncher Statistical System (NCSS 5.1) [11].
Results
Table I shows clinical and biochemical parameters of the
control group and HD patients. As no significant differences for
age, MAP and PWVs were observed between male and female
subjects, the data for both sexes were pooled. While the SAP
was not statistically different, the DAP was slightly but signif-
Table 1. Clinical characteristics and blood chemistry in
hemodialyzed patients and control subjects
Control
subjectsN=90
Hemodialyzed
patientsN=92 Pvalue
Age years 50.8 15.8 49.9 15.9 NS
Body mass index kg/m2 24.8 3.9 23.1 5.0 0.02
MAP mm Hg 110.2 17.2 109.9 19.3 NS
SAP mm Hg 152.6 28.7 161.0 31.5 NS
DAP mm Hg 88.8 13.8 84.5 13.6 0.05
PP mm Hg 63.9 22.0 76.6 23.7 0.0017
Ankle/brachial pressure 1.13 0.12 1.12 0.10 NS
ratio
Calcium x phosphates 2.77 0.50 4.85 1.07 0.00001
Total cholesterol 5.83 1.20 5.30 1.18 0.006
mmol/liter
HDL cholesterol 1.30 0.38 1.16 0.32 0.004
mmol/liter
Triglycerides mmol/liter 1.29 0.72 1.59 0.73 0.005
Apolipoprotein Al 1.80 0.25 1.65 0.37 0.005
glliter
Apolipoprotein B glliter 0.80 0.26 0.80 0.21 NS
Values are mean SD. Abbreviations are: MAP, mean arterial
pressure; SAP, systolic arterial pressure; DAP, diastolic arterial pres-
sure; PP, pulse pressure.
icantly lower in HD patients (P = 0.048). The pulse pressure
was significantly higher in HD patients (P = 0.0017). There
were obvious biochemical abnormalities in HD patients due
mostly to the end-stage renal disease status, and HD patients
had a lower Body Mass Index. HD patients had an increase in
plasma triglycerides (P = 0.005), with a decrease in total and
HDL-cholesterol (P = 0.004). No significant differences were
observed between the total cholesterol-to-HDL cholesterol
ratio. Concentration of apolipoprotein Al was significantly
lower in HD patients (P = 0.004). Apolipoprotein B concentra-
tions were not significantly different in the two groups. Aortic
and iliofemoral axis calcifications were observed in 48 HD
patients (55.3%) and 22 control subjects (24.4%) (P = 0.003).
The ankle/brachial arterial pressure ratio was similar in both
groups. Values of more than 1.3 were observed in 18 HD
patients and 7 controls.
Table 2 shows the arterial and echocardiographic findings.
HD patients had a significantly increased aortic PWV (1113
319 vs. 965 216 cm/sec; P = 0.0016). The femoral and brachial
PWVs were also increased in HD patients (P = 0.048). The
aortic diameters were increased in HD patients. This increase
was observed at all levels, from the root (32.7 4.0 vs. 28.2
2,8 mm; P <0.001), to the aortic bifurcation (16.9 3.1 vs. 14.6
2.2 mm; P < 0.001). The LVEDiD and IVST were signifi-
cantly larger in HD patients. The LVM was increased in HD
patients (P < 0.0001).
As the principal abnormality observed in HD relates to the
physical properties of the aorta, the stepwise regression studies
were concentrated on aortic PWV as being physiologically the
most important [2]. As shown in Table 3, the age and arterial
pressure were, in the two groups, the principal factor related
with aortic PWV. The serum HDL-cholesterol concentration
and arterial calcifications were two other significant factors, but
their roles were slight in comparison to age and blood pressure.
The association of age and pressure with the aortic PWV was
different in controls and HD patients. In control subjects, age
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Table 2. Cardiac and arterial parameters in hemodialyzed patients
and control subjects
Control
subjectsN=90
Hemodialyzed
patientsN=92
P
value
LVEDiD cma 5.27 0.50 5.60 0.65 0.0001
IVST cma 0.92 0.18 1.10 0.20 0.0001
PWT cma 0.80 0.11 0,74 0.10 0.005
LVM ga 198.4 52.2 246 65 0.0001
Aortic PWV cm/s 965 216 1113 319 0.0016
Femoral PWV cm/s 1132 158 1194 180 0.048
Brachial PWV cm/s 1165 156 1230 183 0.048
AODroot mm 28.2 2.8 32.7 4.0 0.001
AODbifure mm 14.6 2.2 16.9 3.1 0,001
Values are mean SD. Abbreviations are: LVEDiD, left ventricular
end-diastolic diameter; IVST, interventricular septal thickness; PWT,
posterior wall thickness; LVM, left ventricular mass; PWV, pulse wave
velocity; AoD, aortic diameter.
a N = 62 in controls, N = 89 in hemodialyzed patients
Table 4. Clinical and arterial parameters in subjects with aortic
calcifications (groups matched for age and arterial pressure)
Control
subjectsN=22
Hemodialyzed
patientsN=28
P
value
Age years 67.7 7.0 6.4.4 6.0 NS
MAP mm Hg 123.0 17.8 117.0 15.9 NS
SAP mm Hg 180.2 30.0 181.1 29.8 NS
DAP m,n Hg 94.8 15.6 86.3 13.2 0.041
PP mm Hg 85.0 21.7 94.9 23.0 NS
Aortic PWV cm/s 1220 178 1379 231 0.0108
Femoral PWV cm/s 1245 155 1257 151 NS
Brachial PWV cm/s 1270 139 1284 171 NS
AOD00t mm 30.1 2.8 34.1 4.4 0.001
AODbil'Urc mm 15.8 2,6 18.6 3.0 0.001
Values are mean SD. Abbreviations are: MAP, mean
pressure; SAP, systolic arterial pressure; DAP, diastolic arterial pres-
sure; PP. pulse pressure; PWV, pulse wave velocity; AoD, aortic
diameter.
arterial
Table 3. Stepwise regression analysis for aortic PWV
and related parameters
Independent variables t-value Probability % RMS
Control subjects
Age 8.47 0.0001 43.7
MAP 4.56 0.0001 10.5
HDL cholesterol —2.15 0.034 2.0
Cal 1.99 0.049 1.6
R squared (R2) = 0.7537
F ratio = 68.1 (P <0.0001)
Root mean square (RMS) = 118.31
Hemodialyzed patients
Age 7.45 0.0001 28,4
MAP 9.91 0.0001 46.9
HDL cholesterol —2.03 0.046 1.8
Cal 1.84 0.069 1.4
R squared (R2) = 0.7602
F ratio = 65.8 (P < 0.0001)
Root mean square (RMS) = 157.30
Abbreviations are: PWV, pulse wave velocity; MAP, mean arterial
pressure; Cal, calcification index.
was responsible for 43.7% of the variability (RMS, root mean
square) of aortic PWV, while arterial pressure was associated
with 10.5% of RMS. In HD patients the arterial pressure played
a more important role (46.9% of RMS) than age (28.4% of
RMS). All other variables tested in the model, including dura-
tion of dialysis, total cholesterol, triglycerides, apolipoprotein
B, calcium-phosphorus product, body mass index, and the
metabolic abnormalities characteristic of end-stage renal fail-
ure, were not found to associated with aortic PWV or its
variability.
In both groups, aortic diameters increased with age (P <
0.0001) and with body surface area (P < 0.001). A significant
positive correlation was observed between the aortic diameters
and aortic PWV. In HD patients the correlation between the
bifurcation aortic diameter and the aortic PWV was significant
(r 0.537; P < 0.0001).
Control subjects with vascular calcifications were signifi-
cantly older (67.7 7 vs. 58.1 11 years; P < 0.001) and more
hypertensive (MAP = 123 17.8 mm Hg) than HD patients
with a similar degree of arterial calcification (110.4 18.3 mm
Table 5. Stepwise regression analysis for LVM and
related parameters
Independent
variables t-value Probability % RMS
Control subjects
BSA 3.20 0.0024 8.3
MAP 4.80 0.00001 19.3
Aortic PWV 1.10 0.2621 —0.3
R squared (R2) = 0.3876
F ratio = 16.45 (P < 0.00001)
Root mean square (RMS) = 41.64
Hemodialyzed patients
BSA 2.30 0.022 2.7
MAP 0.30 0.7405 0.6
Aortic PWV 6.10 0.00001 19.8
R squared (R2) = 0.3741
F ratio = 16.62 (P < 0.00001)
Root mean square (RMS) = 45.40
Abbreviations are: LVM, left ventricular mass; BSA, body surface
area; MAP, mean arterial pressure; PWV, pulse wave velocity.
Hg; P < 0.009). We therefore compared the control subjects
with aortic calcifications with a subset of HD patients with
vascular calcifications matched for age and arterial pressure
(Table 4). The results on Table 4 indicate that HD patients had
an increased aortic PWV and larger aortic diameters.
In control subjects, left ventricular mass (LVM) correlated
with MAP (r = 0.512; P < 0.0001) and aortic PWV (r = 0.425;
P < 0.0001). In HD patients a similar correlation was observed
between LVM and MAP (r = 0.346; P = 0.005) and LVM and
aortic PWV (r = 0.576; P < 0.0001). The stepwise regression
results for LVM as a dependent variable and body surface area,
MAP and aortic PWV as independent variables are shown in
Table 5. The results indicate that in nonuremic controls the
BSA and the MAP are significantly associated with LVM and
its variability, while in HD patients the variables associated
with LVM and its variability, are BSA and aortic PWV (Fig. 1).
These results indicate that in HD patients, as opposed to
control subjects, at constant level of blood pressure, the LVM
is significantly correlated to aortic PWV (partial correlation
coefficient r = 0.478; P < 0.0001).
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Fig. 1. Correlation between left ventricular
mass and aortic pulse wave velocity in2000 hemodialysis patients. (r = 0.576; P <
0.0001).
Discussion
The results of the present study indicate that the cushioning
function of the arteries is altered in patients on chronic hemo-
dialysis (HD). This alteration principally affects the aorta and is
characterized by an increased aortic PWV and an increase in
aortic diameter; these two parameters are positively correlated.
According to the law of the speed of propagation of a
disturbance in a physical system and the Moens-Korteweg
equation [2, 4], the elevated aortic PWV in the presence of an
increased aortic diameter is related to an increase in wall
stiffness (elastic modulus) and/or wall thickness [2, 61.
Physiologic arterial degenerative changes which occur with
aging results in fibroelastic intimal thickening, an increase in
medial ground substance and collagen fibers, degeneration of
elastic fibers and development of calcifications [2, 121. These
changes cause an increase, both in the elastic modulus and in
wall thickness, and are responsible for the increase of arterial
PWV seen with age [2, 6]. The aging process of arteries is
known to be accelerated in hypertension, and high blood
pressure is associated with an increased PWV independent of
age [2, 6]. The increase in PWVs observed in hemodialyzed
patients cannot be explained by differences in age or blood
pressure, and is most probably related to other factors associ-
ated with uremia.
In comparison with nonuremic control subjects, the arteries
from uremic patients show a higher prevalence of fibroelastic
intimal thickening, calcification of the internal elastic lamella
and medial ground substance [121. These changes represent an
acceleration of the normal arterial aging process. The age
related increase in arterial PWV is normally more pronounced
in the aorta than in the limb arteries [6]. Therefore, in agree-
ment with the study by Ibels et al [121, the acceleration of
pathological changes in uremics is most likely to be seen in the
aorta, and this is probably why, in HD patients, aortic PWV is
more accelerated than femoral or brachial PWV. Accelerated
arterial calcifications in HD patients were also observed in the
present study. Nevertheless, the presence of arterial calcifica-
tions was only slightly correlated with aortic PWV. This obser-
vation is in agreement with earlier studies of PWV by Haynes,
Ellis and Weis [13] which showed that the aortic PWV in
patients with clinical and X-ray evidence of arterial calcifica-
tion, but with normal blood pressure, was not different from
that of age-matched controls. Furthermore, as shown in Table
4, when matched for age and arterial pressure, the HD patients
with calcification had increased arterial PWVs in comparison
with control subjects presenting similar degree of calcium
deposition.
Lipid abnormalities in patients receiving hemodialysis are
well documented [14—17] and were also observed in the present
study (Table 1). The concept of accelerated atherosclerosis in
end-stage renal failure [18] has been questioned [3, 19]. Ibels et
a! [12] have shown that lipid depositions were infrequently seen
in arterial samples obtained from hemodialyzed patients, sug-
gesting that it is unlikely that lipid abnormalities are important
in the initiation of vascular disease in uremic patients. There are
conflicting reports on the effects of atherosclerosis on the
cushioning function of arteries and PWV. Reduced arterial
compliance and higher PWV in non-occluded arteries have been
demonstrated in patients with coronary artery disease [20] and
in patients with diabetes mellitus [21]. Other studies have
shown no significant differences in changes in PWV with age in
subjects with a high risk of atherosclerosis, such as familial
hypercholesterolemia [221, or in populations with different
prevalences of atherosclerosis such as Western and Asian
populations [6, 23]. Furthermore, studies of large groups of
Chinese and German populations failed to demonstrate any
association between PWV and serum total cholesterol [6, 24].
In a study on the relationship between lipid fractions and aortic
PWV, Relf et a! [25] found an inverse correlation between
HDL-cholesterol and aortic PWV. In agreement with our
present study the correlation between aortic PWV and HDL-
cholesterol was weak. Therefore, lipid abnormalities and the
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accelerated atherosclerosis in dialysis patients cannot account
for the differences in aortic PWV observed between the control
group and HD patients. This is in agreement with Nakashima
and Tanikawa [26] who showed that, despite a large difference
in the incidence and severity of the atherosclerosis between
Japanese and American populations, aortic distensibility mea-
sured post-mortem was similar in both groups.
The obvious consequences of the decreased compliance and
altered cushioning function of the aorta in HD patients were an
increase in pulse pressure and an alteration in amplification of
the pressure pulse between the aorta and peripheral arteries.
Disturbances in the cushioning function have no ill effect on the
tissues downstream. However, they alter input impedance on
the systemic circulation, with an increase in pulsatile energy
losses in arteries with a marked increase in the ratio of pulsatile
to total external ventricular work, an increase in systolic
pressure with an increased ventricular oxygen requirement, and
a relative decrease in aortic diastolic pressure with a compro-
mised coronary blood-flow capacity [1—6]. All these effects of
reduced aortic compliance affect the heart upstream as an
increased ventricular load. The most obvious clinical implica-
tion in hemodialyzed patients is the arterial pressure-indepen-
dent relationship between the aortic PWV and increased left
ventricular mass. In conclusion, this study demonstrates that
arterial compliance is reduced in HD patients. This decreased
compliance does contribute to an increased afterload, and is
largely a function of sustained hypertension and age. Neverthe-
less uremia per se contributes to this change by mechanisms
whose nature remains to be determined.
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